Dr. Martens (DOCS)

Sector:

Personal Goods

Index:

FTSE 250

 77.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 99.35
  • 52 Week Low: 47.52
  • Currency: UK Pounds
  • Shares Issued: 967.30m
  • Volume: 0
  • Market Cap: £744.82m
  • Beta: 1.05

Latest Deals

Traded Action Notifier PriceAmountValue
11-Dec-25 Transfer From Giles Wilson 0.000p 197 £0.00
11-Dec-25 Buy Giles Wilson 76.25p 197 £150.21
11-Dec-25 Transfer From Ije Nwokori 0.000p 197 £0.00
11-Dec-25 Buy Ije Nwokori 76.25p 197 £150.21
05-Dec-25 Buy Robert Hanson  78.86p 96,000 £75,705.60

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
15-Oct-25 Sell Ije Nwokori 89.67p 298,675 £267,821.88
01-Sep-25 Buy Giles Wilson 91.38p 105,838 £96,711.59
01-Sep-25 Sell Giles Wilson 89.65p 105,785 £94,836.25
05-Dec-25 Buy Robert Hanson  78.86p 96,000 £75,705.60
01-Sep-25 Buy Giles Wilson 91.15p 30,019 £27,360.73

Director Shareholdings

Notifier Holding Value*
Paul Mason 7,875,000 £6,063,750
Ije Nwokori 342,683 £263,866
Giles Wilson 231,691 £178,402
Robert Hanson  200,000 £154,000
Robyn Perriss 94,328 £72,633
Andrew Harrison 76,594 £58,977
Lynne Weedall 40,054 £30,842
Ian Rogers 20,270 £15,608

Major Shareholders

Notifier** Holding Value*
IngreLux S.àr.l 369,942,440 £284,855,679
IngreGrsy Limited 369,942,440 £284,855,679
Permira Holdings Limited 364,142,440 £280,389,679
Artemis Investment Management LLP 107,082,898 £82,453,832
Fidelity Management & Research 32,500,000 £25,025,000
Intertrust Employee Benefit Trustee Limited 135,000 £103,950

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Dr. Martens Market Data

Currency UK Pounds
Share Price 77.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 99.35
52 Week Low 47.52
Volume 0
Shares Issued 967.30m
Market Cap £744.82m
Beta 1.05

Dr. Martens Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
28.38% below the market average28.38% below the market average28.38% below the market average28.38% below the market average28.38% below the market average
77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average
Price Trend
32.86% above the market average32.86% above the market average32.86% above the market average32.86% above the market average32.86% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income
48.6% below the market average48.6% below the market average48.6% below the market average48.6% below the market average48.6% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
99.52% below the market average99.52% below the market average99.52% below the market average99.52% below the market average99.52% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Dr. Martens Dividends

  Latest Previous
  Interim Final
Ex-Div 05-Mar-26 28-Aug-25
Paid 09-Apr-26 08-Oct-25
Amount 0.85p 1.70p

Trades for --2026

Time Volume / Share Price
0 @ 0.000p

Dr. Martens Key Personnel

Chair Paul Mason
CEO Ije Nwokori
CFO Giles Wilson

Top of Page